Amateur Hour Continues

Why should everyone that doesn't need insulin subsidize the cost for those that do?
Are you serious?
What percent of insulin do you believe is purchased through health insurance plans?
Everyone with health insurance is who is currently paying the ridiculous price.
 
  • Like
Reactions: tvolsfan
Are you serious?
What percent of insulin do you believe is purchased through health insurance plans?
Everyone with health insurance is who is currently paying the ridiculous price.
You shut your mouth. Companies should be able to price people out of life saving drugs, and arguing against that basically makes you Karl Marx.
 
  • Like
Reactions: luthervol
Are you serious?
What percent of insulin do you believe is purchased through health insurance plans?
Everyone with health insurance is who is currently paying the ridiculous price.

The bill caps the co-pay at $35 (that's all it does) so everyone else paying insurance premiums would be subsidizing anything additional.
 
And I'm sure you would gladly support legislation limiting price gouging for life saving drugs.

Here is a good article on why insulin is so expensive and it's not simply price gouging, it's the barriers the US government has put up to keep generics off the market. This bill will do nothing to reduce the actual price of insulin, if anything it will encourage more price gouging since the consumer won't see it at the point of sell.

Insulin insulated: barriers to competition and affordability in the United States insulin market
 
Here is a good article on why insulin is so expensive and it's not simply price gouging, it's the barriers the US government has put up to keep generics off the market. This bill will do nothing to reduce the actual price of insulin, if anything it will encourage more price gouging since the consumer won't see it at the point of sell.

Insulin insulated: barriers to competition and affordability in the United States insulin market
Here are some solutions form your linked article:

Several members of Congress have made proposals to address insulin pricing specifically. In late 2018, Senator Elizabeth Warren (D-MA) suggested that the federal government starts its own generic manufacturing plant, with insulin put forth as one product of focus.9 In July 2019, Senators Jeanne Shaheen (R-NH), Tom Carper (D-DE), Kevin Cramer (R-ND), and Susan Collins (R-ME) filed proposed legislation aimed at creating a ‘new insulin pricing model’ predominantly by regulating insulin rebates from pharmacy benefit managers.10 In February 2019, Representatives Peter Welch (D-VT) and Francis Rooney (R-FL) submitted a bill to allow importation of affordable insulin from Canada and possibly other countries.11

Sounds like we need to go after those who opposed these proposals.
 
Here are some solutions form your linked article:

Several members of Congress have made proposals to address insulin pricing specifically. In late 2018, Senator Elizabeth Warren (D-MA) suggested that the federal government starts its own generic manufacturing plant, with insulin put forth as one product of focus.9 In July 2019, Senators Jeanne Shaheen (R-NH), Tom Carper (D-DE), Kevin Cramer (R-ND), and Susan Collins (R-ME) filed proposed legislation aimed at creating a ‘new insulin pricing model’ predominantly by regulating insulin rebates from pharmacy benefit managers.10 In February 2019, Representatives Peter Welch (D-VT) and Francis Rooney (R-FL) submitted a bill to allow importation of affordable insulin from Canada and possibly other countries.11

Sounds like we need to go after those who opposed these proposals.

Of course Luther stopped reading when he saw proposals to use taxpayer money and more government control to "fix" the problem.

Why doesn't the government pull it's head out of it's ass and fix the regulatory inconsistency that prevents generic insulin from coming to the market? Oh, I think we all know why.

Insulin is a biologic, which is a drug ‘derived from living materials, including viruses, therapeutic serums, toxins and antitoxins, vaccines, blood and blood products, and cells, tissues, and gene therapy products’.72 Most drugs are small molecule drugs, which are regulated under the Federal Food Drug and Cosmetic Act (FDCA) and approved under a New Drug Application (NDA) or associated accelerated pathway.73 Most biologics are approved through a Biologics License Application (BLA) under the Public Health Service Act (PHS Act).74 However, insulin was approved before the Food and Drug Administration (FDA) created the biologics approval process and was regulated as a small molecule drug under the FDCA until March 23, 2020.75

This regulatory inconsistency served as a practical barrier for introducing competition into the insulin market, particularly biosimilar competition. Biosimilars are drugs that are ‘highly similar to the [biologic] reference product notwithstanding minor differences in clinically inactive components’ and has ‘no clinically meaningful differences…in terms of the safety, purity, and potency of the product’ with the reference biologic.76 Under the PHS Act, biosimilars must be based on an approved reference biologic product.77 Because insulin had been regulated as a small drug, there was no reference biologic insulin product for which a biosimilar could be developed.78
 
Of course Luther stopped reading when he saw proposals to use taxpayer money and more government control to "fix" the problem.

Why doesn't the government pull it's head out of it's ass and fix the regulatory inconsistency that prevents generic insulin from coming to the market? Oh, I think we all know why.
Sounds like an easy fix. Move insulin under the appropriate regulatory arm.
Let's go after the people who have restricted this movement.
 
  • Like
Reactions: tvolsfan
She helped Trump win Florida twice. Now she could lead his expected 2024 campaign | CNN Politics

This line, about Trump wanting to put this lady in charge of his campaign:

"After all the drama of his first term and the election, everyone was enriching themselves through Trump, and he ******* hates that. It became clear after several people mentioned her name that Susie wouldn't be like that," said a person close to Trump.

XdOL.gif
 
Sounds like an easy fix. Move insulin under the appropriate regulatory arm.
Let's go after the people who have restricted this movement.

Absolutely let's go after them. Some of your sacred cows would fall but so be it right?
 
Perhaps Republicans, unlike their liberal Democratic colleagues, actually understand basic economics and realize that price controls result in supply shortages.
Considering how cheap insulin is to manufacture, this seems unlikely. I'm sure people will be willing to make a substantial profit even if they can't make an extortionate profit.

And no, Republicans aren't worried about supply shortages. They're worried about donors.
 
  • Like
Reactions: luthervol
Considering how cheap insulin is to manufacture, this seems unlikely. I'm sure people will be willing to make a substantial profit even if they can't make an extortionate profit.

And no, Republicans aren't worried about supply shortages. They're worried about donors.

Both parties worry about donors and that’s why neither one of them are interested in changing the rules to allow competition.
 
  • Like
Reactions: 0nelilreb
Advertisement

Back
Top